Examples of 'lipid formulation' in a sentence
Meaning of "lipid formulation"
lipid formulation - A mixture or composition containing lipids, such as fats or oils, used in various fields including pharmaceuticals, cosmetics, and food products
How to use "lipid formulation" in a sentence
Basic
Advanced
lipid formulation
The dsRNA may be formulated in a lipid formulation.
A lipid formulation comprising a cationic lipid having the structure wherein.
The dsRNA can be formulated in a lipid formulation.
A lipid formulation of the present invention is not limited to any particular use or application.
Peroxidase activity in the lipid formulation.
The net charge of the lipid formulation may range from negative to neutral.
The nucleic acid is fully encapsulated in the lipid formulation.
A lipid formulation comprising a cationic lipid of claim 1.
Preparation of lipid formulation.
Once absorbed systemically the active principle will be released from the lipid formulation.
A method of preparing a lipid formulation containing a compound that is,.
In an embodiment, the dsRNA is formulated in a lipid formulation.
A lipid formulation containing a compound that is,.
The octreotide concentration in the respective lipid formulation is indicated in the figure.
Lipid formulation of strontium ibuprofen for intramuscular injection ( sustained release ).
See also
Aqueous phase concentration of free API in the lipid formulation of the tested compounds.
The lipid formulation of claim 3, further comprising at least one apolipoprotein.
Preparation of RNA-binding agent and transfection lipid formulation.
In one aspect, the improved lipid formulation also includes a targeting lipid.
In one embodiment, the pharmaceutical compositions further comprise a lipid formulation.
The lipid formulation of any one of claims 1 to 4 where the formulation is a liposomal formulation.
Preferably, the net charge of the lipid formulation is negative.
The lipid formulation of any one of claims 1 to 10 which is prepared by extrusion.
In one implementation, the pharmaceutical compositions further comprise a lipid formulation.
The lipid formulation of a dsRNA or vehicle control is administered by standard intravenous ( i . v. ).
In a preferred embodiment, the nucleic acid is fully encapsulated in the lipid formulation.
The dsRNA of claim 1 to 2, wherein the lipid formulation further comprises cholesterol.
The pharmaceutical composition of claim 1, wherein the dsRNA is formulated in a lipid formulation.
In addition, it is preferred that the lipid formulation contain no more than about 10 % cholesterol.
In another embodiment, the peptide is formulated in a cationic or non-cationic lipid formulation.
The lipid formulation of claim 4, wherein the therapeutic agent is an antisense, siRNA or ribozyme.
In certain preferred embodiments, the pharmaceutically acceptable lipid formulation further comprises a targeting moiety.
The lipid formulation according to claim 14, wherein said lysophosphatide is a mono-oleoyl lysophosphatidylcholine.
The dsRNA of claim 1, wherein the dsRNA is formulated in a lipid formulation.
Preferably the lipid formulation is administered less than 72 hours prior to chemotherapy, surgery or radiotherapy.
Preparation of liquid non-aqueous lipid formulation of somatostatin ( SOM ).
Currently, a lipid formulation of di-isopropyl phenol ( propofol ) is the most highly used anaesthetic agent.
This is compared to the pharmacokinetic profile of compounds of formula ( I ′ ) in a lipid formulation.
More preferably the lipid formulation is administered less than 24 hours after chemotherapy, surgery or radiotherapy.
In vivo performance of liquid non-aqueous lipid formulation of somatostatin ( SOM ).
The lipid formulation may be a LNP 11 formulation.
A pharmaceutical composition, e.g., a composition described herein, may include a lipid formulation.
Lipid formulation / sufficient quantity of SI ⁺ buffer.
The dsRNA of claims 1-6, wherein the dsRNA is formulated in a lipid formulation.
Lipid formulations have been classified according to the lipid formulation classification system ( LFCS ) as follows,.
The dsRNA of items 1-20, wherein the dsRNA is formulated in a lipid formulation.
The lipid formulation of any one of claims 1 to 5, having.
In certain embodiments, a pharmaceutical composition, e.g., a composition described herein, includes a lipid formulation.
The lipid formulation of claim 6 where the degree of encapsulation is above 80 %.
The dsRNA of claim 1 to 3, wherein the lipid formulation further comprises polyethyleneglycol ( PEG ) or PEG-DMG.
You'll also be interested in:
Examples of using Lipid
Show more
Regulation of lipid metabolism in the case of hyperlipidaemia
Increased cholesterol and blood lipid values
Mean lipid fraction based on wet weight
Examples of using Formulation
Show more
Reduction in budget formulation cycle time assessed
Formulation and communication of conditional interpretative declarations
Child rights policy formulation and coordination
